Teradyne (TER) Q3 2026 Earnings Call Transcript

Teradyne reported Q3 revenue of $1.306 billion, up 70% year over year, and non-GAAP EPS of $2.29, up more than 150%; both exceeded the high end of management’s guidance. AI-related revenue was more than 60% of total, while gross margin increased 60 basis points year over year to 59.1%; robotics also reached quarterly-record revenue of $96 million and profitability. For Q4, management guided to revenue of $1.25 billion–$1.35 billion and non-GAAP EPS of $1.95–$2.25, and expects healthy growth in 2027, while noting customer shipment timing and longer capacity lead times as uncertainties.

Analysis

The key read-through is not simply AI capex strength: TER is monetizing a higher test-intensity mix and opening a second-source path at customers where the incumbent has a strong compute position. That creates share-gain potential, but qualifications, customer test-cell readiness and TER’s own capacity are the gating variables; demand forecasts alone do not guarantee shipments. The HBM stack-height shift is a favorable mix mechanism for TER if it means more tested stacks per wafer supply, but should be treated as incremental upside until customer designs and test content confirm it.

Near term, Q4 revenue guidance supports a durable elevated run rate, while lower sequential margins and EPS guidance underscore that mix, launches and investment can interrupt operating leverage. Inventory is not a pure demand signal: management characterized the build as partly constrained-component coverage and partly normalization. A sudden customer pull-in could therefore expose lead-time limits rather than produce immediate upside.

Over 1–3 months, the January model update and order phasing are the main catalysts. The stated Q1 visibility is qualified by intra-quarter test-cell timing. Over 6–18 months, compute dual-sourcing and memory capacity ramps are the core earnings drivers; robotics appears more like a 2028 option than a near-term valuation anchor. CPO should also be discounted: test economics and assembly readiness make timing uncertain, while copper and pluggable solutions preserve TER’s exposure if adoption slips.

Contrarian risk: exceptionally strong results can obscure that a large share of growth is tied to AI infrastructure deployment schedules and that compute share gains are still developing. If customer ramps slip, the fixed investment and inventory position could weaken incremental margins before end demand disappears.

Key Decisions for Investors

• Prefer accumulating TER on post-earnings weakness rather than chasing strength; hold the thesis through the January outlook update and 2027 customer ramps. Do not assign near-term value to robotics or CPO optionality. Without current valuation and price data, avoid setting a target or sizing the position from this call alone.
• Use the January model update as the principal 1–3 month catalyst check: verify compute program timing, memory growth, quarterly phasing and whether margins hold as capacity expands. Reduce exposure if guidance or backlog indicates customer ramps have shifted materially later, or if margin deterioration exceeds the company’s stated mix/investment explanation.
• Track TER against Advantest for evidence of actual compute share capture, not just dual-source qualifications. Falsification: TER’s customer ramps fail to convert into shipments, or its lead times prevent it from serving unforecast demand while the incumbent retains the incremental orders.
• Treat FormFactor’s announced relationship with TER as an ecosystem signal, not yet an earnings forecast; verify transaction closing, product scope and revenue contribution before trading FORM on this basis.